Resveratrol reduces acute lung injury in a LPS‑induced sepsis mouse model via activation of Sirt1 Retraction in /10.3892/mmr.2023.13137

Li,Tongxun; Zhang,Jinglan; Feng,Jiliang; Li,Qiang; Wu,Lisong; Ye,Qing; Sun,Jianping; Lin,Yi; Zhang,Mengran; Huang,Rui; Cheng,Jun; Cao,Yongmei; Xiang,Guoan; Zhang,Jinqian; Wu,Qinghua

doi:10.3892/mmr.2013.1444

Resveratrol reduces acute lung injury in a LPS‑induced sepsis mouse model via activation of Sirt1

Retraction in: /10.3892/mmr.2023.13137

Authors:
- Tongxun Li
- Jinglan Zhang
- Jiliang Feng
- Qiang Li
- Lisong Wu
- Qing Ye
- Jianping Sun
- Yi Lin
- Mengran Zhang
- Rui Huang
- Jun Cheng
- Yongmei Cao
- Guoan Xiang
- Jinqian Zhang
- Qinghua Wu
View Affiliations

Affiliations: Stroke Center, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, P.R. China , Surgery Intensive Care Unit, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, P.R. China, Department of Pathology, Beijing Youan Hospital, Capital Medical University, Beijing 100054, P.R. China, Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, P.R. China, Cardio-Thoracic Vascular Surgery, The 306th Hospital of PLA, Beijing 100101, P.R. China, Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, P.R. China, Department of General Surgery, The Second People's Hospital of Guangdong Province, Guangzhou 510515, P.R. China, International Mongolian Hospital, Hohhot of Inner Mongolia, Hohhot 010065, P.R. China, Department of Vascular Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, P.R. China
Published online on: April 26, 2013 https://doi.org/10.3892/mmr.2013.1444
Pages: 1889-1895

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The development of acute lung injury (ALI) during sepsis almost doubles the mortality rate of patients. The efficacy of current treatment strategies is low as treatment is usually initiated following the onset of symptoms. Inflammation is one of the main mechanisms of autoimmune disorders and is a common feature of sepsis. The suppression of inflammation is therefore an important mechanism for the treatment of sepsis. Sirtuin 1 (Sirt1) has been demonstrated to play a role in the regulation of inflammation. Resveratrol, a potent Sirt1 activator, exhibits anti‑inflammatory properties. However, the role of resveratrol for the treatment of ALI during sepsis is not fully understood. In the present study, the anti‑inflammatory role of Sirt1 in the lipopolysaccharide (LPS)‑induced TC‑1 cell line and its therapeutic role in ALI was investigated in a mouse model of sepsis. The upregulation of matrix metalloproteinase-9, interleukin (IL)‑1β, IL‑6 and inducible nitric oxide synthase was induced by LPS in the mouse model of sepsis and the TC‑1 cell line, and resveratrol suppressed the overexpression of these proinflammatory molecules in a dose‑dependent manner. Resveratrol decreased pulmonary edema in the mouse model of sepsis induced by LPS. In addition, resveratrol improved lung function and reduced pathological alterations in the mouse model of sepsis. Knockdown of Sirt1 by RNA interference resulted in an increased susceptibility of TC‑1 cells to LPS stimulation and diminished the anti‑inflammatory effect of resveratrol. These results demonstrated that resveratrol inhibits LPS‑induced ALI and inflammation via Sirt1, and indicated that Sirt1 is an efficient target for the regulation of LPS‑induced ALI and inflammation. The present study provides insights into the treatment of ALI during sepsis.

View Figures

View References

1	Lee WL and Slutsky AS: Sepsis and endothelial permeability. N Engl J Med. 363:689–691. 2010. View Article : Google Scholar : PubMed/NCBI
2	Hotchkiss RS and Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med. 348:138–150. 2003. View Article : Google Scholar : PubMed/NCBI
3	Angus DC, Linde-Zwirble WT, Lidicker J, et al: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome and associated costs of care. Crit Care Med. 29:1303–1310. 2001. View Article : Google Scholar : PubMed/NCBI
4	Marshall JC, Vincent JL, Guyatt G, et al: Outcome measures for clinical research in sepsis: a report of the 2nd Cambridge Colloquium of the International Sepsis Forum. Crit Care Med. 33:1708–1716. 2005. View Article : Google Scholar : PubMed/NCBI
5	Herridge MS, Cheung AM, Tansey CM, et al: One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med. 348:683–693. 2003.PubMed/NCBI
6	Chung YJ, Jarvis B and Pestka J: Modulation of lipopolysaccharide-induced proinflammatory cytokine production by satratoxins and other macrocyclic trichothecenes in the murine macrophage. J Toxicol Environ Health A. 66:379–391. 2003. View Article : Google Scholar
7	Brandolini L, Asti C, Ruggieri V, et al: Lipopolysaccharide-induced lung injury in mice. II Evaluation of functional damage in isolated parenchyma strips. Pulm Pharmacol Ther. 13:71–78. 2000. View Article : Google Scholar : PubMed/NCBI
8	Bucher M and Taeger K: Endothelin-receptor gene-expression in rat endotoxemia. Intensive Care Med. 28:642–647. 2002. View Article : Google Scholar : PubMed/NCBI
9	Emery DA, Nagaraja KV, Sivanandan V, et al: Endotoxin lipopolysaccharide from Escherichia coli and its effects on the phagocytic function of systemic and pulmonary macrophages in turkeys. Avian Dis. 35:901–909. 1991.
10	Esbenshade AM, Newman JH, Lams PM, et al: Respiratory failure after endotoxin infusion in sheep: lung mechanics and lung fluid balance. J Appl Physiol. 53:967–976. 1982.PubMed/NCBI
11	Müller G, Steinbach G, Berndt A and Köhler H: Effects of various applications of lipopolysaccharides on blood parameters of pigs. J Vet Med B Infect Dis Vet Public Health. 49:429–437. 2002.PubMed/NCBI
12	Lentsch AB, Czermak BJ, Bless NM, et al: Essential role of alveolar macrophages in intrapulmonary activation of NF-kappaB. Am J Respir Cell Mol Biol. 20:692–698. 1999. View Article : Google Scholar : PubMed/NCBI
13	Lentsch AB and Ward PA: Regulation of experimental lung inflammation. Respir Physiol. 128:17–22. 2001. View Article : Google Scholar : PubMed/NCBI
14	Rojas M, Woods CR, Mora AL, et al: Endotoxin-induced lung injury in mice: structural, functional and biochemical responses. Am J Physiol Lung Cell Mol Physiol. 288:L333–L341. 2005. View Article : Google Scholar : PubMed/NCBI
15	Howitz KT, Bitterman KJ, Cohen HY, et al: Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature. 425:191–196. 2003. View Article : Google Scholar : PubMed/NCBI
16	Kojima K, Ohhashi R, Fujita Y, et al: A role for SIRT1 in cell growth and chemoresistance in prostate cancer PC3 and DU145 cells. Biochem Biophys Res Commun. 373:423–428. 2008. View Article : Google Scholar : PubMed/NCBI
17	Ford J, Jiang M and Milner J: Cancer-specific functions of SIRT1 enable human epithelial cancer cell growth and survival. Cancer Res. 65:10457–10463. 2005. View Article : Google Scholar : PubMed/NCBI
18	Yang SR, Wright J, Bauter M, et al: Sirtuin regulates cigarette smoke-induced proinflammatory mediator release via RelA/p65 NF-kappaB in macrophages in vitro and in rat lungs in vivo: implications for chronic inflammation and aging. Am J Physiol Lung Cell Mol Physiol. 292:L567–L576. 2007. View Article : Google Scholar : PubMed/NCBI
19	Yeung F, Hoberg JE, Ramsey CS, et al: Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 23:2369–2380. 2004. View Article : Google Scholar : PubMed/NCBI
20	Rajendrasozhan S, Yang SR, Kinnula VL and Rahman I: SIRT1, an antiinflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 177:861–870. 2008. View Article : Google Scholar : PubMed/NCBI
21	Singh UP, Singh NP, Singh B, et al: Resveratrol (trans-3,5,4′-trihydroxystilbene) induces silent mating type information regulation-1 and down-regulates nuclear transcription factor-kappaB activation to abrogate dextran sulfate sodium-induced colitis. J Pharmacol Exp Ther. 332:829–839. 2010.
22	Borra MT, Smith BC and Denu JM: Mechanism of human SIRT1 activation by resveratrol. J Biol Chem. 280:17187–17195. 2005. View Article : Google Scholar : PubMed/NCBI
23	Bishayee A, Waghray A, Barnes KF, et al: Suppression of the inflammatory cascade is implicated in resveratrol chemoprevention of experimental hepatocarcinogenesis. Pharm Res. 27:1080–1091. 2010. View Article : Google Scholar : PubMed/NCBI
24	Knobloch J, Sibbing B, Jungck D, et al: Resveratrol impairs the release of steroid-resistant inflammatory cytokines from human airway smooth muscle cells in chronic obstructive pulmonary disease. J Pharmacol Exp Ther. 335:788–798. 2010. View Article : Google Scholar
25	Chung EY, Kim BH, Hong JT, et al: Resveratrol downregulates interferon-gamma-inducible inflammatory genes in macrophages: molecular mechanism via decreased STAT-1 activation. J Nutr Biochem. 22:902–909. 2011. View Article : Google Scholar
26	Csaki C, Keshishzadeh N, Fischer K and Shakibaei M: Regulation of inflammation signalling by resveratrol in human chondrocytes in vitro. Biochem Pharmacol. 75:677–687. 2008. View Article : Google Scholar : PubMed/NCBI
27	Donnelly LE, Newton R, Kennedy GE, et al: Anti-inflammatory effects of resveratrol in lung epithelial cells: molecular mechanisms. Am J Physiol Lung Cell Mol Physiol. 287:L774–L783. 2004. View Article : Google Scholar : PubMed/NCBI
28	Elmali N, Baysal O, Harma A, et al: Effects of resveratrol in inflammatory arthritis. Inflammation. 30:1–6. 2007. View Article : Google Scholar : PubMed/NCBI
29	Olholm J, Paulsen SK, Cullberg KB, et al: Antiinflammatory effect of resveratrol on adipokine expression and secretion in human adipose tissue explants. Int J Obes (Lond). 34:1546–1553. 2010. View Article : Google Scholar : PubMed/NCBI
30	Kim DH, Longo M, Han Y, et al: Interferon induction by siRNAs and ssRNAs synthesised by phage polymerase. Nat Biotechnol. 22:321–325. 2004. View Article : Google Scholar : PubMed/NCBI
31	Peterson BT, Brooks JA and Zack AG: Use of microwave oven for determination of postmortem water volume of lungs. J Appl Physiol. 52:1661–1663. 1982.PubMed/NCBI
32	Riva DR, Oliveira MB, Rzezinski AF, et al: Recruitment maneuver in pulmonary and extrapulmonary experimental acute lung injury. Crit Care Med. 36:1900–1908. 2008. View Article : Google Scholar : PubMed/NCBI
33	Pássaro CP, Silva PL, Rzezinski AF, et al: Pulmonary lesion induced by low and high positive end-expiratory pressure levels during protective ventilation in experimental acute lung injury. Crit Care Med. 37:1011–1017. 2009.PubMed/NCBI
34	Baydur A, Behrakis PK, Zin WA, et al: A simple method for assessing the validity of the esophageal balloon technique. Am Rev Respir Dis. 126:788–791. 1982.PubMed/NCBI
35	Baydur A, Sassoon CS and Stiles CM: Partitioning of respiratory mechanics in young adults. Effects of duration of anesthesia. Am Rev Respir Dis. 135:165–172. 1987.PubMed/NCBI
36	Leite-Junior JH, Garcia CS, Souza-Fernandes AB, et al: Methylprednisolone improves lung mechanics and reduces the inflammatory response in pulmonary but not in extrapulmonary mild acute lung injury in mice. Crit Care Med. 36:2621–2628. 2008. View Article : Google Scholar : PubMed/NCBI
37	Gursoy-Ozdemir Y, Qiu J, Matsuoka N, et al: Cortical spreading depression activates and upregulates MMP-9. J Clin Invest. 113:1447–1455. 2004. View Article : Google Scholar : PubMed/NCBI
38	Qiu J, Xu J, Zheng Y, et al: High-mobility group box 1 promotes metalloproteinase-9 upregulation through Toll-like receptor 4 after cerebral ischemia. Stroke. 41:2077–2082. 2010. View Article : Google Scholar : PubMed/NCBI
39	Matsuda N, Hattori Y, Takahashi Y, et al: Therapeutic effect of in vivo transfection of transcription factor decoy to NF-kappaB on septic lung in mice. Am J Physiol Lung Cell Mol Physiol. 287:L1248–L1255. 2004.PubMed/NCBI
40	Oshikawa K and Sugiyama Y: Gene expression of Toll-like receptors and associated molecules induced by inflammatory stimuli in the primary alveolar macrophage. Biochem Biophys Res Commun. 305:649–655. 2003. View Article : Google Scholar : PubMed/NCBI
41	Yull FE, Han W, Jansen ED, et al: Bioluminescent detection of endotoxin effects on HIV-1 LTR-driven transcription in vivo. J Histochem Cytochem. 51:741–749. 2003. View Article : Google Scholar : PubMed/NCBI
42	Pietrantoni C, Minai OA, Yu NC, et al: Respiratory failure and sepsis are the major causes of ICU admissions and mortality in survivors of lung transplants. Chest. 123:504–509. 2003. View Article : Google Scholar : PubMed/NCBI
43	Takala A, Nupponen I, Kylänpää-Bäck ML and Repo H: Markers of inflammation in sepsis. Ann Med. 34:614–623. 2002. View Article : Google Scholar
44	Lagouge M, Argmann C, Gerhart-Hines Z, et al: Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell. 127:1109–1122. 2006. View Article : Google Scholar : PubMed/NCBI
45	Sun W, Wang W, Kim J, et al: Anti-cancer effect of resveratrol is associated with induction of apoptosis via a mitochondrial pathway alignment. Adv Exp Med Biol. 614:179–186. 2008. View Article : Google Scholar : PubMed/NCBI
46	Zhang HN, Li L, Gao P, et al: Involvement of the p65/RelA subunit of NF-kappaB in TNF-alpha-induced SIRT1 expression in vascular smooth muscle cells. Biochem Biophys Res Commun. 397:569–575. 2010. View Article : Google Scholar : PubMed/NCBI
47	Lee SJ and Kim MM: Resveratrol with antioxidant activity inhibits matrix metalloproteinase via modulation of SIRT1 in human fibrosarcoma cells. Life Sci. 88:465–472. 2011. View Article : Google Scholar : PubMed/NCBI
48	Niederer F, Ospelt C, Brentano F, et al: SIRT1 overexpression in the rheumatoid arthritis synovium contributes to proinflammatory cytokine production and apoptosis resistance. Ann Rheum Dis. 70:1866–1873. 2011. View Article : Google Scholar : PubMed/NCBI